PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search
BNF Chapter
BNF Paragraph
Please select a BNF Chapter.
Search Results : Migraine (prevention) (Flunarizine dihydrochloride - Migraine (prevention))
Records returned : 18 (on 05 Dec 2024 at 01:36:20). Return to search results for ' Migraine (prevention) '.
Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
04.07.04
Red
Formulations :
- Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Important
Restricted to use in patients who are intolerant or refractory to other treatment options
02.04.00
04.07.04
Green
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
04.07.04
04.08.01
Green
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Pregnancy Prevention Plan required for females of childbearing potential.
02.05.05
04.07.04
Green
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Off-label use
04.07.03
04.07.04
Green
Formulations :
- Oral solution
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
04.07.04
04.08.01
Green (see narrative)
Formulations :
- Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Important
Pregnancy Prevention Plan required for females of childbearing potential.
Capsules (Sprinkle) reserved for use in patients who cannot swallow tablets.
Green (see narrative)
Formulations :
- Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
Important
Pregnancy Prevention Plan required for females of childbearing potential.
Only use where patient cannot swallow tablets or capsules (sprinkle) are not suitable.
04.07.04
Green (see narrative)
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Review existing patients and consider alternative.
Discontinuation of pizotifen requires gradual withdrawal.
04.07.04
Red
Formulations :
- Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
04.07.04
Red
Formulations :
- Oral lyophilisates
ASPH
RSFT
SASH
SABP
Primary Care
Important
For episodic migraine only
Red
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Red
Formulations :
- Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
04.07.04
04.09.03
Red
Formulations :
- Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Important
For Chronic migraine only
Neurology teams only
04.07.04
Red
Formulations :
- Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
Preferred
04.07.04
Red
Formulations :
- Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
02.05.02
04.07.04
Non Formulary
ASPH
RSFT
SASH
SABP
Primary Care
04.07.03
04.07.04
04.08.01
Non Formulary
Formulations :
- Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
04.07.03
04.07.04
04.08.01
Non Formulary
Formulations :
- Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
For information about the icons and status values within this site, please refer to the keys below.
Icon/Links Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq form to be completed
NICE
Traffic Light Status Key
Red
Amber
Green
Black
Amber Star
Green (see narrative)
Non Formulary
See Below
N/A
Blue
Green - Black
See narrative
Do not initiate in new patients